Catalyst Pharmaceuticals, Inc. (CPRX)
23.34
+0.05
(+0.21%)
USD |
NASDAQ |
Dec 31, 16:00
23.06
-0.28
(-1.20%)
After-Hours: 05:09
Catalyst Pharmaceuticals Research and Development Expense (TTM): 14.70M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Collegium Pharmaceutical, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 344.78M |
| Amicus Therapeutics, Inc. | 142.29M |
| Rigel Pharmaceuticals, Inc. | 28.24M |
| Krystal Biotech, Inc. | 55.37M |